{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:59:08Z","timestamp":1791831548996,"version":"4.3.4"},"reference-count":192,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00036"],"award-info":[{"award-number":["PI19\/00036"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00220"],"award-info":[{"award-number":["PI20\/00220"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Secretaria d\u2019Universitats i Recerca del Departament d\u2019Economia i Coneixement","award":["2017-SGR-1753"],"award-info":[{"award-number":["2017-SGR-1753"]}]},{"name":"Secretaria d\u2019Universitats i Recerca del Departament d\u2019Economia i Coneixement","award":["2017-SGR-517"],"award-info":[{"award-number":["2017-SGR-517"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer and the third leading cause of cancer death worldwide. Closely associated with liver inflammation and fibrosis, hepatocyte cell death is a common trigger for acute and chronic liver disease arising from different etiologies, including viral hepatitis, alcohol abuse, and fatty liver. In this review, we discuss the contribution of different types of cell death, including apoptosis, necroptosis, pyroptosis, or autophagy, to the progression of liver disease and the development of HCC. Interestingly, inflammasomes have recently emerged as pivotal innate sensors with a highly pathogenic role in various liver diseases. In this regard, an increased inflammatory response would act as a key element promoting a pro-oncogenic microenvironment that may result not only in tumor growth, but also in the formation of a premetastatic niche. Importantly, nonparenchymal hepatic cells, such as liver sinusoidal endothelial cells, hepatic stellate cells, and hepatic macrophages, play an important role in establishing the tumor microenvironment, stimulating tumorigenesis by paracrine communication through cytokines and\/or angiocrine factors. Finally, we update the potential therapeutic options to inhibit tumorigenesis, and we propose different mechanisms to consider in the tumor microenvironment field for HCC resolution.<\/jats:p>","DOI":"10.3390\/cancers14010048","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T10:16:18Z","timestamp":1640254578000},"page":"48","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2920-2306","authenticated-orcid":false,"given":"Ester","family":"Garc\u00eda-Pras","sequence":"first","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic, University of Barcelona, IDIBAPS, CIBERHED, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2364-6675","authenticated-orcid":false,"given":"Anabel","family":"Fern\u00e1ndez-Iglesias","sequence":"additional","affiliation":[{"name":"Liver Vascular Biology Research Group, IDIBAPS, CIBEREHD, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7736-4089","authenticated-orcid":false,"given":"Jordi","family":"Gracia-Sancho","sequence":"additional","affiliation":[{"name":"Liver Vascular Biology Research Group, IDIBAPS, CIBEREHD, 08036 Barcelona, Spain"},{"name":"Department for Biomedical Research, Hepatology, Inselspital, University of Bern, 3008 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-300X","authenticated-orcid":false,"given":"Sof\u00eda","family":"P\u00e9rez-del-Pulgar","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic, University of Barcelona, IDIBAPS, CIBERHED, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1083\/jcb.201903090","article-title":"The cell biology of the hepatocyte: A membrane trafficking machine","volume":"218","author":"Schulze","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.redox.2017.01.012","article-title":"Metabolic zonation of the liver: The oxygen gradient revisited","volume":"11","author":"Kietzmann","year":"2017","journal-title":"Redox Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"655697","DOI":"10.3389\/fimmu.2021.655697","article-title":"Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies","volume":"12","author":"Giraud","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"026","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","article-title":"Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance","volume":"147","author":"Luedde","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-Based Diagnosis, Staging, and Treatment of Patients with Hepatocellular Carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/cphy.c120020","article-title":"Apoptosis and Necrosis in the Liver","volume":"3","author":"Guicciardi","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: A matter of life and death","volume":"15","author":"Schwabe","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41584-020-0455-8","article-title":"Cell death in chronic inflammation: Breaking the cycle to treat rheumatic disease","volume":"16","author":"Anderton","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2020.04.001","article-title":"Lytic cell death in metabolic liver disease","volume":"73","author":"Gautheron","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1310050","article-title":"Necroptosis","volume":"370","author":"Linkermann","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3389\/fimmu.2017.01728","article-title":"Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"a008656","DOI":"10.1101\/cshperspect.a008656","article-title":"Caspase Functions in Cell Death and Disease","volume":"5","author":"McIlwain","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12585","article-title":"Death begets a new beginning","volume":"280","author":"Bosurgi","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejcb.2011.10.001","article-title":"The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer","volume":"91","author":"Liedtke","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2017.08.010","article-title":"A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development","volume":"32","author":"Boege","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molcel.2017.01.022","article-title":"Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory \u201cFADDosome\u201d Complex upon TRAIL Stimulation","volume":"65","author":"Henry","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.molcel.2017.01.021","article-title":"The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2","volume":"65","author":"Hartwig","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ccell.2016.11.009","article-title":"RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer","volume":"31","author":"Schneider","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ccell.2015.10.001","article-title":"NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis","volume":"28","author":"Kondylis","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"14231","DOI":"10.1073\/pnas.2005353117","article-title":"Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma","volume":"117","author":"Tan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jhep.2019.11.008","article-title":"Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease","volume":"72","author":"Majdi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.fob.2014.08.007","article-title":"Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure","volume":"4","author":"Takemoto","year":"2014","journal-title":"FEBS Open Bio"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.4049\/jimmunol.1601428","article-title":"Prolonged Ischemia Triggers Necrotic Depletion of Tissue-Resident Macrophages to Facilitate Inflammatory Immune Activation in Liver Ischemia Reperfusion Injury","volume":"198","author":"Yue","year":"2017","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/path.5248","article-title":"The pathological features of regulated necrosis","volume":"247","author":"Tonnus","year":"2019","journal-title":"J. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/hep.21062","article-title":"Apoptosis and necrosis in the liver: A tale of two deaths?","volume":"43","author":"Malhi","year":"2006","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.gastro.2006.03.045","article-title":"c-Jun N-Terminal Kinase Plays a Major Role in Murine Acetaminophen Hepatotoxicity","volume":"131","author":"Gunawan","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2004.09.015","article-title":"Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice","volume":"42","author":"Masubuchi","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","article-title":"HMGB1 signals through toll-like receptor (TLR) 4 and TLR2","volume":"26","author":"Yu","year":"2006","journal-title":"Shock"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Xiao, J., Ding, Y., Huang, J., Li, Q., Liu, Y., Ni, W., Zhang, Y., Zhu, Y., Chen, L., and Chen, B. (2014). The Association of HMGB1 Gene with the Prognosis of HCC. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089097"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1172\/JCI91786","article-title":"HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis","volume":"128","author":"Hernandez","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1158\/0008-5472.CAN-14-2147","article-title":"High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21\u2013Mediated Matrix Metalloproteinase Activity","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajpath.2019.10.012","article-title":"Necroptosis in the Pathophysiology of Disease","volume":"190","author":"Khoury","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: The expanding network of non-apoptotic cell death pathways","volume":"15","author":"Linkermann","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.cell.2016.11.047","article-title":"Roles of Caspases in Necrotic Cell Death","volume":"167","author":"Yuan","year":"2016","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: An intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","article-title":"Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance","volume":"38","author":"Kaczmarek","year":"2013","journal-title":"Immunity"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1038\/ncomms7282","article-title":"RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL","volume":"6","author":"Lawlor","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.1402167","article-title":"A RIPK3\u2013Caspase 8 Complex Mediates Atypical Pro\u2013IL-1\u03b2 Processing","volume":"194","author":"Moriwaki","year":"2015","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/cr.2015.56","article-title":"Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics","volume":"25","author":"Koo","year":"2015","journal-title":"Cell Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01044.x","article-title":"Caspase-1-induced pyroptotic cell death","volume":"243","author":"Miao","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tcb.2014.12.009","article-title":"Mechanisms of inflammasome activation: Recent advances and novel insights","volume":"25","author":"Vanaja","year":"2015","journal-title":"Trends Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3389\/fimmu.2018.02201","article-title":"Inflammasome: A Double-Edged Sword in Liver Diseases","volume":"9","author":"Luan","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_51","first-page":"G1248","article-title":"Inflammasome-mediated regulation of hepatic stellate cells","volume":"296","author":"Watanabe","year":"2009","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_52","first-page":"344","article-title":"Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology","volume":"3","author":"Weiskirchen","year":"2014","journal-title":"HepatoBiliary Surg. Nutr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.yexmp.2014.08.006","article-title":"The inflammasome in alcoholic hepatitis: Its relationship with Mallory\u2013Denk body formation","volume":"97","author":"Peng","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0024-3205(86)90554-0","article-title":"Serum interleukin-1 (IL-1) activity in alcoholic hepatitis","volume":"39","author":"McClain","year":"1986","journal-title":"Life Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2013","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","article-title":"NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"36107","DOI":"10.1038\/srep36107","article-title":"Targeting inflammasome\/IL-1 pathways for cancer immunotherapy","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"50766","DOI":"10.18632\/oncotarget.9391","article-title":"The inflammasome: An emerging therapeutic oncotarget for cancer prevention","volume":"7","author":"Zhiyu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2015.08.013","article-title":"The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity","volume":"43","author":"Arabzadeh","year":"2015","journal-title":"Immunity"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e1129484","DOI":"10.1080\/2162402X.2015.1129484","article-title":"Linking cancer-induced Nlrp3 inflammasome activation to efficient NK cell-mediated immunosurveillance","volume":"5","author":"Dagenais","year":"2016","journal-title":"OncoImmunology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/labinvest.2013.126","article-title":"Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression","volume":"94","author":"Wei","year":"2013","journal-title":"Lab. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/labinvest.2015.63","article-title":"Estrogen suppresses hepatocellular carcinoma cells through ER\u03b2-mediated upregulation of the NLRP3 inflammasome","volume":"95","author":"Wei","year":"2015","journal-title":"Lab. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Yazdani, H.O., Huang, H., and Tsung, A. (2019). Autophagy: Dual Response in the Development of Hepatocellular Carcinoma. Cells, 8.","DOI":"10.3390\/cells8020091"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"57707","DOI":"10.18632\/oncotarget.17202","article-title":"The role of autophagy in hepatocellular carcinoma: Friend or foe","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e1405142","DOI":"10.1080\/23723556.2017.1405142","article-title":"Autophagy and mitophagy in hepatocarcinogenesis","volume":"5","author":"Liu","year":"2018","journal-title":"Mol. Cell. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1038\/cddis.2013.35","article-title":"Paradoxical role of autophagy in the dysplastic and tumor-forming stages of hepatocarcinoma development in rats","volume":"4","author":"Sun","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ccell.2016.04.006","article-title":"p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells","volume":"29","author":"Umemura","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ccell.2020.05.018","article-title":"PKC\u03bb\/\u03b9 Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression","volume":"38","author":"Kudo","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1159\/000485285","article-title":"Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma","volume":"44","author":"Sun","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jhep.2016.04.019","article-title":"ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1\u03b1","volume":"65","author":"Wu","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41419-018-0329-z","article-title":"Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e103181","DOI":"10.15252\/embj.2019103181","article-title":"RNA m 6 A methylation regulates sorafenib resistance in liver cancer through FOXO 3-mediated autophagy","volume":"39","author":"Lin","year":"2020","journal-title":"EMBO J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/gutjnl-2019-318830","article-title":"miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy","volume":"69","author":"Xu","year":"2019","journal-title":"Gut"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1080\/15548627.2019.1580105","article-title":"The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance","volume":"15","author":"Huang","year":"2019","journal-title":"Autophagy"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41419-018-0681-z","article-title":"CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma","volume":"9","author":"Lu","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_78","first-page":"1733","article-title":"The tumor microenvironment in hepatocellular carcinoma (Review)","volume":"40","author":"Libra","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","article-title":"Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer","volume":"36","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma","volume":"144","author":"Toffanin","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2016.04.018","article-title":"Sinusoidal communication in liver fibrosis and regeneration","volume":"65","author":"Marrone","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Fessas, P., Spina, P., Boldorini, R., Pirisi, M., Minisini, R., Mauri, F., Simpson, F., Olivieri, P., Gennari, A., and Wong, C. (2021). Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13092137"},{"key":"ref_83","first-page":"221","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"Marrone","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","article-title":"Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis","volume":"11","author":"An","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jhep.2011.07.010","article-title":"A role for autophagy during hepatic stellate cell activation","volume":"55","author":"Thoen","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","article-title":"Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues","volume":"142","author":"Rozenfeld","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2020.12.015","article-title":"Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production","volume":"160","author":"Myojin","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.27822","article-title":"Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma","volume":"62","author":"Ji","year":"2015","journal-title":"Hepatology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of Activated Stellate Cells Limits Liver Fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"ref_91","first-page":"728","article-title":"FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome","volume":"22","author":"Li","year":"2020","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/0008-5472.CAN-11-3317","article-title":"Hepatocyte-Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular Carcinoma","volume":"72","author":"Coulouarn","year":"2012","journal-title":"Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","article-title":"Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche","volume":"51","author":"Bonnardel","year":"2019","journal-title":"Immunity"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fmed.2021.627927","article-title":"Activated Hepatic Stellate Cells Induce Infiltration and Formation of CD163+ Macrophages via CCL2\/CCR2 Pathway","volume":"8","author":"Xi","year":"2021","journal-title":"Front. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2018.00018","article-title":"Exosome-Based Cell-Cell Communication in the Tumor Microenvironment","volume":"6","author":"Maia","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/carcin\/bgz096","article-title":"Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment","volume":"41","author":"Li","year":"2019","journal-title":"Carcinogenesis"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/hep.31792","article-title":"Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression","volume":"73","author":"Song","year":"2021","journal-title":"Hepatology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1\/CXCL12 Secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-19-2691","article-title":"Interaction with CD68 and regulation of GAS6 expression by endosialin in fibroblasts drives recruitment and polarization of macrophages in hepatocellular carcinoma","volume":"80","author":"Yang","year":"2020","journal-title":"Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"100115","DOI":"10.1016\/j.jhepr.2020.100115","article-title":"The Liver Matrisome\u2014Looking beyond Collagens","volume":"2","author":"Arteel","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: Molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1038\/s41598-019-43759-6","article-title":"Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis","volume":"9","author":"Lachowski","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_104","first-page":"E83","article-title":"Sensing the environment: A historical perspective on integrin signal transduction","volume":"4","author":"Miranti","year":"2002","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1349-7006.2004.tb02197.x","article-title":"Transforming growth factor-beta1-induced apoptosis is blocked by beta1-integrin-mediated mitogen-activated protein kinase activation in human hepatoma cells","volume":"95","author":"Zhang","year":"2004","journal-title":"Cancer Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1006\/bbrc.2000.3177","article-title":"TGF-\u03b21 Modulated the Expression of \u03b15\u03b21 Integrin and Integrin-Mediated Signaling in Human Hepatocarcinoma Cells","volume":"274","author":"Cai","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.24108","article-title":"Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells","volume":"53","author":"Schrader","year":"2011","journal-title":"Hepatology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3892\/or.2013.2650","article-title":"ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells","volume":"30","author":"Yuan","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/jhep.2003.50205","article-title":"ADAM12 in human liver cancers: TGF-\u03b2-regulated expression in stellate cells is associated with matrix remodeling","volume":"37","author":"Pabic","year":"2003","journal-title":"Hepatology"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Th\u00e9ret, N., Bouezzeddine, F., Azar, F., Diab-Assaf, M., and Legagneux, V. (2021). ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment. Cancers, 13.","DOI":"10.3390\/cancers13071563"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut\u2013liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis","volume":"28","author":"Roh","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2019.03.016","article-title":"Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers","volume":"71","author":"Lefere","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1111\/febs.15566","article-title":"Matrix stiffness-mediated effects on macrophages polarization and their LOXL2 expression","volume":"288","author":"Xing","year":"2020","journal-title":"FEBS J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"100145","DOI":"10.1016\/j.jhepr.2020.100145","article-title":"Nuclear deformation mediates liver cell mechanosensing in cirrhosis","volume":"2","author":"Wang","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2016.12.004","article-title":"Autophagy-deficient Kupffer cells promote tumorigenesis by enhancing mtROS-NF-\u03baB-IL1\u03b1\/\u03b2-dependent inflammation and fibrosis during the preneoplastic stage of hepatocarcinogenesis","volume":"388","author":"Sun","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","article-title":"Distinct Role of Macrophages in Different Tumor Microenvironments","volume":"66","author":"Lewis","year":"2006","journal-title":"Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2014.10.029","article-title":"Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma","volume":"62","author":"Yeung","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/gutjnl-2014-307671","article-title":"Tim-3 fosters HCC development by enhancing TGF-\u03b2-mediated alternative activation of macrophages","volume":"64","author":"Yan","year":"2015","journal-title":"Gut"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"E5900","DOI":"10.1073\/pnas.1706559114","article-title":"Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses","volume":"114","author":"Chew","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Manicardi, N., Fern\u00e1ndez-Iglesias, A., Abad-Jord\u00e0, L., Royo, F., Azkargorta, M., Ortega-Ribera, M., Sanfeliu-Redondo, D., Mart\u00ednez-Alcocer, A., Elortza, F., and Hessheimer, A. (2021). Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature. Cancers, 13.","DOI":"10.3390\/cancers13112688"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/liv.12262","article-title":"Endothelial transdifferentiation in hepatocellular carcinoma: Loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival","volume":"33","author":"Mogler","year":"2013","journal-title":"Liver Int."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.26016","article-title":"Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics","volume":"57","author":"Liaskou","year":"2012","journal-title":"Hepatology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<612::AID-IJC17>3.0.CO;2-D","article-title":"Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis","volume":"71","author":"Brodt","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature09493","article-title":"Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration","volume":"468","author":"Ding","year":"2010","journal-title":"Nature"},{"key":"ref_131","first-page":"G246","article-title":"Angiocrine signaling in the hepatic sinusoids in health and disease","volume":"311","author":"Kostallari","year":"2016","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1038\/s41598-019-49473-7","article-title":"Liver sinusoidal endothelial cell ICAM-1 mediated tumor\/endothelial crosstalk drives the development of liver metastasis by initiating inflammatory and angiogenic responses","volume":"9","author":"Benedicto","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1038\/s41598-017-10498-5","article-title":"Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: Multiplex analysis of serum markers","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3389\/fphys.2020.00990","article-title":"The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver","volume":"11","author":"Wilkinson","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1158\/0008-5472.CAN-20-0242","article-title":"YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF\/c-MET Signaling in Liver Tumorigenesis","volume":"80","author":"Thomann","year":"2020","journal-title":"Cancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1038\/s41388-021-01863-w","article-title":"HGF\/c-MET pathway in cancer: From molecular characterization to clinical evidence","volume":"40","author":"Fu","year":"2021","journal-title":"Oncogene"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12967-020-02244-9","article-title":"Angiocrine endothelium: From physiology to cancer","volume":"18","author":"Pasquier","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccell.2017.01.007","article-title":"Endothelial Notch1 Activity Facilitates Metastasis","volume":"31","author":"Wieland","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/j.gastro.2011.12.052","article-title":"Disruption of Notch1 Induces Vascular Remodeling, Intussusceptive Angiogenesis, and Angiosarcomas in Livers of Mice","volume":"142","author":"Dill","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2020.08.040","article-title":"Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma","volume":"183","author":"Sharma","year":"2020","journal-title":"Cell"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/s41467-021-23408-1","article-title":"The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2","volume":"12","author":"Ash","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1073\/pnas.97.8.3884","article-title":"Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model","volume":"97","author":"Fang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000109079","article-title":"Phenotypic and Functional Differences between Human Liver Cancer Endothelial Cells and Liver Sinusoidal Endothelial Cells","volume":"45","author":"Wu","year":"2007","journal-title":"J. Vasc. Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in Advanced Hepatocellular Carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep4.1360","article-title":"Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte-Mediated Paracrine Mechanism","volume":"3","author":"Manicardi","year":"2019","journal-title":"Hepatol. Commun."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/liv.12570","article-title":"The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis","volume":"35","author":"Barreyro","year":"2014","journal-title":"Liver Int."},{"key":"ref_149","first-page":"885","article-title":"Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension","volume":"72","author":"Bosch","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2019.11.024","article-title":"A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis","volume":"72","author":"Harrison","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"339ra69","DOI":"10.1126\/scitranslmed.aad3099","article-title":"The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia","volume":"8","author":"Brumatti","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/cdd.2014.83","article-title":"Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout","volume":"21","author":"Ehlken","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1053\/j.gastro.2011.08.037","article-title":"Loss of Caspase-8 Protects Mice Against Inflammation-Related Hepatocarcinogenesis but Induces Non-Apoptotic Liver Injury","volume":"141","author":"Liedtke","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.celrep.2020.01.028","article-title":"OTULIN Prevents Liver Inflammation and Hepatocellular Carcinoma by Inhibiting FADD- and RIPK1 Kinase-Mediated Hepatocyte Apoptosis","volume":"30","author":"Verboom","year":"2020","journal-title":"Cell Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/bph.14653","article-title":"Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3","volume":"176","author":"Chen","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e00365","DOI":"10.1002\/prp2.365","article-title":"Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers","volume":"5","author":"Weisel","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/acs.jmedchem.6b01751","article-title":"Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases","volume":"60","author":"Harris","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2015.04.018","article-title":"Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells","volume":"365","author":"Liese","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fphar.2018.01298","article-title":"The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2018.09.022","article-title":"Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma","volume":"70","author":"Chen","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41374-018-0177-6","article-title":"Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"99","author":"Zhang","year":"2019","journal-title":"Lab. Investig."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Baeza-Raja, B., Goodyear, A., Liu, X., Lam, K., Yamamoto, L., Li, Y., Dodson, G.S., Takeuchi, T., Kisseleva, T., and Brenner, D.A. (2020). Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0234038"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s43440-020-00064-8","article-title":"Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis","volume":"72","author":"Zhang","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"ref_165","first-page":"827","article-title":"E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells","volume":"27","author":"Wei","year":"2019","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1158\/1535-7163.MCT-13-1043","article-title":"Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma","volume":"13","author":"Zhai","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1038\/cddis.2013.18","article-title":"Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells","volume":"4","author":"Tai","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Fan, S.-H., Wang, Y.-Y., Lu, J., Zheng, Y.-L., Wu, D.-M., Li, M.-Q., Hu, B., Zhang, Z.-F., Cheng, W., and Shan, Q. (2014). Luteoloside Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma Cells by Inhibition of NLRP3 Inflammasome. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089961"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2147\/DDDT.S243383","article-title":"Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation","volume":"14","author":"Li","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ijc.31343","article-title":"Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver","volume":"143","author":"Marquez","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2020.08.033","article-title":"Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling","volume":"74","author":"Winkler","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1078-0432.CCR-11-1102","article-title":"Targeting Tumor-Associated Endothelial Cells: Anti-VEGFR2 Immunoliposomes Mediate Tumor Vessel Disruption and Inhibit Tumor Growth","volume":"18","author":"Wicki","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A Randomized Trial of Bevacizumab, an Anti\u2013Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer","volume":"349","author":"Yang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.smim.2018.02.002","article-title":"The dark side of tumor-associated endothelial cells","volume":"35","author":"Ugel","year":"2018","journal-title":"Semin. Immunol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fcell.2020.00766","article-title":"Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment\u2014New Findings and Future Perspectives","volume":"8","author":"Nagl","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.redox.2018.09.007","article-title":"Curcumol induces RIPK1\/RIPK3 complex-dependent necroptosis via JNK1\/2-ROS signaling in hepatic stellate cells","volume":"19","author":"Jia","year":"2018","journal-title":"Redox Biol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Chang, Y.J., Hsu, S.L., Liu, Y.T., Lin, Y.H., Lin, M.H., Huang, S.J., Ho, J.-A.A., and Wu, L.-C. (2015). Gallic Acid Induces Necroptosis via TNF\u2013\u03b1 Signaling Pathway in Activated Hepatic Stellate Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120713"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/s41388-018-0320-2","article-title":"LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy","volume":"37","author":"Rossow","year":"2018","journal-title":"Oncogene"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MPA.0000000000000741","article-title":"4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated with Pancreatic Cancer Cells","volume":"46","author":"Nagase","year":"2017","journal-title":"Pancreas"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41575-021-00444-2","article-title":"Regulation and functional roles of chemokines in liver diseases","volume":"18","author":"Cao","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.22952","article-title":"CCR2 promotes hepatic fibrosis in mice","volume":"50","author":"Seki","year":"2009","journal-title":"Hepatology"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1136\/gutjnl-2013-306294","article-title":"CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis","volume":"63","author":"Ehling","year":"2014","journal-title":"Gut"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1073\/pnas.1117610109","article-title":"TGF-blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e00056","DOI":"10.14309\/ctg.0000000000000056","article-title":"A Phase 2 Study of Galunisertib (TGF-\u03b21 Receptor Type I Inhibitor) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma","volume":"10","author":"Kelley","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","article-title":"Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma","volume":"66","author":"Li","year":"2015","journal-title":"Gut"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/cmi.2014.102","article-title":"CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not","volume":"12","author":"Polimeno","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e2015433118","DOI":"10.1073\/pnas.2015433118","article-title":"A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment","volume":"118","author":"Song","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41467-021-23864-9","article-title":"WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/1\/48\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:51:48Z","timestamp":1760169108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/1\/48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":192,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["cancers14010048"],"URL":"https:\/\/doi.org\/10.3390\/cancers14010048","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]}}}